The global market for Famciclovir was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.

North American market for Famciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Famciclovir include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals, Beijing Jialin Pharmaceutical, HETERO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir.

The Famciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Famciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Famciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Famciclovir Market Report

Report Metric	Details
Report Name	Famciclovir Market
Segment by Type	125 mg Tablets 250 mg Tablets 500 mg Tablets
Segment by Application	Cold Sores Genital Herpes Shingles
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals, Beijing Jialin Pharmaceutical, HETERO, Hainan choitec Pharmaceuticals, Shandong Luoxin Pharmaceutical Group, Chengdu Diao Pharmaceutical Group, HISUN
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Famciclovir Market report?

Ans: The main players in the Famciclovir Market are Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals, Beijing Jialin Pharmaceutical, HETERO, Hainan choitec Pharmaceuticals, Shandong Luoxin Pharmaceutical Group, Chengdu Diao Pharmaceutical Group, HISUN

What are the Application segmentation covered in the Famciclovir Market report?

Ans: The Applications covered in the Famciclovir Market report are Cold Sores, Genital Herpes, Shingles

What are the Type segmentation covered in the Famciclovir Market report?

Ans: The Types covered in the Famciclovir Market report are 125 mg Tablets, 250 mg Tablets, 500 mg Tablets

1 Famciclovir Market Overview

1.1 Product Definition

1.2 Famciclovir by Type

1.2.1 Global Famciclovir Market Value Comparison by Type (2024 VS 2031)

1.2.2 125 mg Tablets

1.2.3 250 mg Tablets

1.2.4 500 mg Tablets

1.3 Famciclovir by Application

1.3.1 Global Famciclovir Market Value by Application (2024 VS 2031)

1.3.2 Cold Sores

1.3.3 Genital Herpes

1.3.4 Shingles

1.4 Global Famciclovir Market Size Estimates and Forecasts

1.4.1 Global Famciclovir Revenue 2020-2031

1.4.2 Global Famciclovir Sales 2020-2031

1.4.3 Global Famciclovir Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Famciclovir Market Competition by Manufacturers

2.1 Global Famciclovir Sales Market Share by Manufacturers (2020-2025)

2.2 Global Famciclovir Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Famciclovir Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Famciclovir, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Famciclovir, Product Type & Application

2.7 Global Key Manufacturers of Famciclovir, Date of Enter into This Industry

2.8 Global Famciclovir Market Competitive Situation and Trends

2.8.1 Global Famciclovir Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Famciclovir Players Market Share by Revenue

2.8.3 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Famciclovir Market Scenario by Region

3.1 Global Famciclovir Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Famciclovir Sales by Region: 2020-2031

3.2.1 Global Famciclovir Sales by Region: 2020-2025

3.2.2 Global Famciclovir Sales by Region: 2026-2031

3.3 Global Famciclovir Revenue by Region: 2020-2031

3.3.1 Global Famciclovir Revenue by Region: 2020-2025

3.3.2 Global Famciclovir Revenue by Region: 2026-2031

3.4 North America Famciclovir Market Facts & Figures by Country

3.4.1 North America Famciclovir Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Famciclovir Sales by Country (2020-2031)

3.4.3 North America Famciclovir Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Famciclovir Market Facts & Figures by Country

3.5.1 Europe Famciclovir Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Famciclovir Sales by Country (2020-2031)

3.5.3 Europe Famciclovir Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Famciclovir Market Facts & Figures by Region

3.6.1 Asia Pacific Famciclovir Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Famciclovir Sales by Region (2020-2031)

3.6.3 Asia Pacific Famciclovir Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Famciclovir Market Facts & Figures by Country

3.7.1 Latin America Famciclovir Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Famciclovir Sales by Country (2020-2031)

3.7.3 Latin America Famciclovir Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Famciclovir Market Facts & Figures by Country

3.8.1 Middle East and Africa Famciclovir Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Famciclovir Sales by Country (2020-2031)

3.8.3 Middle East and Africa Famciclovir Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Famciclovir Sales by Type (2020-2031)

4.1.1 Global Famciclovir Sales by Type (2020-2025)

4.1.2 Global Famciclovir Sales by Type (2026-2031)

4.1.3 Global Famciclovir Sales Market Share by Type (2020-2031)

4.2 Global Famciclovir Revenue by Type (2020-2031)

4.2.1 Global Famciclovir Revenue by Type (2020-2025)

4.2.2 Global Famciclovir Revenue by Type (2026-2031)

4.2.3 Global Famciclovir Revenue Market Share by Type (2020-2031)

4.3 Global Famciclovir Price by Type (2020-2031)

5 Segment by Application

5.1 Global Famciclovir Sales by Application (2020-2031)

5.1.1 Global Famciclovir Sales by Application (2020-2025)

5.1.2 Global Famciclovir Sales by Application (2026-2031)

5.1.3 Global Famciclovir Sales Market Share by Application (2020-2031)

5.2 Global Famciclovir Revenue by Application (2020-2031)

5.2.1 Global Famciclovir Revenue by Application (2020-2025)

5.2.2 Global Famciclovir Revenue by Application (2026-2031)

5.2.3 Global Famciclovir Revenue Market Share by Application (2020-2031)

5.3 Global Famciclovir Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Famciclovir Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Mylan

6.2.1 Mylan Company Information

6.2.2 Mylan Description and Business Overview

6.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mylan Famciclovir Product Portfolio

6.2.5 Mylan Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Famciclovir Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Cipla

6.4.1 Cipla Company Information

6.4.2 Cipla Description and Business Overview

6.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cipla Famciclovir Product Portfolio

6.4.5 Cipla Recent Developments/Updates

6.5 Hikma

6.5.1 Hikma Company Information

6.5.2 Hikma Description and Business Overview

6.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hikma Famciclovir Product Portfolio

6.5.5 Hikma Recent Developments/Updates

6.6 Apotex

6.6.1 Apotex Company Information

6.6.2 Apotex Description and Business Overview

6.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Apotex Famciclovir Product Portfolio

6.6.5 Apotex Recent Developments/Updates

6.7 Aurobindo Pharma

6.7.1 Aurobindo Pharma Company Information

6.7.2 Aurobindo Pharma Description and Business Overview

6.7.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Aurobindo Pharma Famciclovir Product Portfolio

6.7.5 Aurobindo Pharma Recent Developments/Updates

6.8 Macleods Pharmaceuticals

6.8.1 Macleods Pharmaceuticals Company Information

6.8.2 Macleods Pharmaceuticals Description and Business Overview

6.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio

6.8.5 Macleods Pharmaceuticals Recent Developments/Updates

6.9 Beijing Jialin Pharmaceutical

6.9.1 Beijing Jialin Pharmaceutical Company Information

6.9.2 Beijing Jialin Pharmaceutical Description and Business Overview

6.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio

6.9.5 Beijing Jialin Pharmaceutical Recent Developments/Updates

6.10 HETERO

6.10.1 HETERO Company Information

6.10.2 HETERO Description and Business Overview

6.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.10.4 HETERO Famciclovir Product Portfolio

6.10.5 HETERO Recent Developments/Updates

6.11 Hainan choitec Pharmaceuticals

6.11.1 Hainan choitec Pharmaceuticals Company Information

6.11.2 Hainan choitec Pharmaceuticals Description and Business Overview

6.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio

6.11.5 Hainan choitec Pharmaceuticals Recent Developments/Updates

6.12 Shandong Luoxin Pharmaceutical Group

6.12.1 Shandong Luoxin Pharmaceutical Group Company Information

6.12.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview

6.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio

6.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

6.13 Chengdu Diao Pharmaceutical Group

6.13.1 Chengdu Diao Pharmaceutical Group Company Information

6.13.2 Chengdu Diao Pharmaceutical Group Description and Business Overview

6.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio

6.13.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates

6.14 HISUN

6.14.1 HISUN Company Information

6.14.2 HISUN Description and Business Overview

6.14.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2020-2025)

6.14.4 HISUN Famciclovir Product Portfolio

6.14.5 HISUN Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Famciclovir Industry Chain Analysis

7.2 Famciclovir Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Famciclovir Production Mode & Process Analysis

7.4 Famciclovir Sales and Marketing

7.4.1 Famciclovir Sales Channels

7.4.2 Famciclovir Distributors

7.5 Famciclovir Customer Analysis

8 Famciclovir Market Dynamics

8.1 Famciclovir Industry Trends

8.2 Famciclovir Market Drivers

8.3 Famciclovir Market Challenges

8.4 Famciclovir Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Macleods Pharmaceuticals

Beijing Jialin Pharmaceutical

Hetero

Hainan choitec Pharmaceuticals

Shandong Luoxin Pharmaceutical Group

Chengdu Diao Pharmaceutical Group

HISUN

List of Tables

Table 1. Global Famciclovir Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Famciclovir Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Famciclovir Market Competitive Situation by Manufacturers in 2024

Table 4. Global Famciclovir Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Famciclovir Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Famciclovir Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Famciclovir Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Famciclovir Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Famciclovir, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Famciclovir, Product Type & Application

Table 12. Global Key Manufacturers of Famciclovir, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Famciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Famciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Famciclovir Sales by Region (2020-2025) & (K Units)

Table 18. Global Famciclovir Sales Market Share by Region (2020-2025)

Table 19. Global Famciclovir Sales by Region (2026-2031) & (K Units)

Table 20. Global Famciclovir Sales Market Share by Region (2026-2031)

Table 21. Global Famciclovir Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Famciclovir Revenue Market Share by Region (2020-2025)

Table 23. Global Famciclovir Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Famciclovir Revenue Market Share by Region (2026-2031)

Table 25. North America Famciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Famciclovir Sales by Country (2020-2025) & (K Units)

Table 27. North America Famciclovir Sales by Country (2026-2031) & (K Units)

Table 28. North America Famciclovir Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Famciclovir Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Famciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Famciclovir Sales by Country (2020-2025) & (K Units)

Table 32. Europe Famciclovir Sales by Country (2026-2031) & (K Units)

Table 33. Europe Famciclovir Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Famciclovir Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Famciclovir Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Famciclovir Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Famciclovir Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Famciclovir Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Famciclovir Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Famciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Famciclovir Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Famciclovir Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Famciclovir Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Famciclovir Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Famciclovir Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Famciclovir Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Famciclovir Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Famciclovir Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Famciclovir Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Famciclovir Sales (K Units) by Type (2020-2025)

Table 51. Global Famciclovir Sales (K Units) by Type (2026-2031)

Table 52. Global Famciclovir Sales Market Share by Type (2020-2025)

Table 53. Global Famciclovir Sales Market Share by Type (2026-2031)

Table 54. Global Famciclovir Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Famciclovir Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Famciclovir Revenue Market Share by Type (2020-2025)

Table 57. Global Famciclovir Revenue Market Share by Type (2026-2031)

Table 58. Global Famciclovir Price (USD/Unit) by Type (2020-2025)

Table 59. Global Famciclovir Price (USD/Unit) by Type (2026-2031)

Table 60. Global Famciclovir Sales (K Units) by Application (2020-2025)

Table 61. Global Famciclovir Sales (K Units) by Application (2026-2031)

Table 62. Global Famciclovir Sales Market Share by Application (2020-2025)

Table 63. Global Famciclovir Sales Market Share by Application (2026-2031)

Table 64. Global Famciclovir Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Famciclovir Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Famciclovir Revenue Market Share by Application (2020-2025)

Table 67. Global Famciclovir Revenue Market Share by Application (2026-2031)

Table 68. Global Famciclovir Price (USD/Unit) by Application (2020-2025)

Table 69. Global Famciclovir Price (USD/Unit) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Novartis Famciclovir Product

Table 74. Novartis Recent Developments/Updates

Table 75. Mylan Company Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Mylan Famciclovir Product

Table 79. Mylan Recent Developments/Updates

Table 80. Teva Company Information

Table 81. Teva Description and Business Overview

Table 82. Teva Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Teva Famciclovir Product

Table 84. Teva Recent Developments/Updates

Table 85. Cipla Company Information

Table 86. Cipla Description and Business Overview

Table 87. Cipla Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Cipla Famciclovir Product

Table 89. Cipla Recent Developments/Updates

Table 90. Hikma Company Information

Table 91. Hikma Description and Business Overview

Table 92. Hikma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Hikma Famciclovir Product

Table 94. Hikma Recent Developments/Updates

Table 95. Apotex Company Information

Table 96. Apotex Description and Business Overview

Table 97. Apotex Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Apotex Famciclovir Product

Table 99. Apotex Recent Developments/Updates

Table 100. Aurobindo Pharma Company Information

Table 101. Aurobindo Pharma Description and Business Overview

Table 102. Aurobindo Pharma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Aurobindo Pharma Famciclovir Product

Table 104. Aurobindo Pharma Recent Developments/Updates

Table 105. Macleods Pharmaceuticals Company Information

Table 106. Macleods Pharmaceuticals Description and Business Overview

Table 107. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Macleods Pharmaceuticals Famciclovir Product

Table 109. Macleods Pharmaceuticals Recent Developments/Updates

Table 110. Beijing Jialin Pharmaceutical Company Information

Table 111. Beijing Jialin Pharmaceutical Description and Business Overview

Table 112. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Beijing Jialin Pharmaceutical Famciclovir Product

Table 114. Beijing Jialin Pharmaceutical Recent Developments/Updates

Table 115. HETERO Company Information

Table 116. HETERO Description and Business Overview

Table 117. HETERO Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. HETERO Famciclovir Product

Table 119. HETERO Recent Developments/Updates

Table 120. Hainan choitec Pharmaceuticals Company Information

Table 121. Hainan choitec Pharmaceuticals Description and Business Overview

Table 122. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Hainan choitec Pharmaceuticals Famciclovir Product

Table 124. Hainan choitec Pharmaceuticals Recent Developments/Updates

Table 125. Shandong Luoxin Pharmaceutical Group Company Information

Table 126. Shandong Luoxin Pharmaceutical Group Description and Business Overview

Table 127. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Shandong Luoxin Pharmaceutical Group Famciclovir Product

Table 129. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

Table 130. Chengdu Diao Pharmaceutical Group Company Information

Table 131. Chengdu Diao Pharmaceutical Group Description and Business Overview

Table 132. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Chengdu Diao Pharmaceutical Group Famciclovir Product

Table 134. Chengdu Diao Pharmaceutical Group Recent Developments/Updates

Table 135. HISUN Company Information

Table 136. HISUN Description and Business Overview

Table 137. HISUN Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. HISUN Famciclovir Product

Table 139. HISUN Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Famciclovir Distributors List

Table 143. Famciclovir Customers List

Table 144. Famciclovir Market Trends

Table 145. Famciclovir Market Drivers

Table 146. Famciclovir Market Challenges

Table 147. Famciclovir Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Famciclovir

Figure 2. Global Famciclovir Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Famciclovir Market Share by Type: 2024 & 2031

Figure 4. 125 mg Tablets Product Picture

Figure 5. 250 mg Tablets Product Picture

Figure 6. 500 mg Tablets Product Picture

Figure 7. Global Famciclovir Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Famciclovir Market Share by Application: 2024 & 2031

Figure 9. Cold Sores

Figure 10. Genital Herpes

Figure 11. Shingles

Figure 12. Global Famciclovir Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Famciclovir Market Size (2020-2031) & (US$ Million)

Figure 14. Global Famciclovir Sales (2020-2031) & (K Units)

Figure 15. Global Famciclovir Average Price (USD/Unit) & (2020-2031)

Figure 16. Famciclovir Report Years Considered

Figure 17. Famciclovir Sales Share by Manufacturers in 2024

Figure 18. Global Famciclovir Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Famciclovir Players: Market Share by Revenue in Famciclovir in 2024

Figure 20. Famciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Famciclovir Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Famciclovir Sales Market Share by Country (2020-2031)

Figure 23. North America Famciclovir Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Famciclovir Sales Market Share by Country (2020-2031)

Figure 27. Europe Famciclovir Revenue Market Share by Country (2020-2031)

Figure 28. Germany Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Famciclovir Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Famciclovir Revenue Market Share by Region (2020-2031)

Figure 35. China Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Famciclovir Sales Market Share by Country (2020-2031)

Figure 46. Latin America Famciclovir Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Famciclovir Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Famciclovir Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Famciclovir Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Famciclovir by Type (2020-2031)

Figure 56. Global Revenue Market Share of Famciclovir by Type (2020-2031)

Figure 57. Global Famciclovir Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Famciclovir by Application (2020-2031)

Figure 59. Global Revenue Market Share of Famciclovir by Application (2020-2031)

Figure 60. Global Famciclovir Price (USD/Unit) by Application (2020-2031)

Figure 61. Famciclovir Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions